Renaissance Technologies LLC lessened its stake in Haleon plc (NYSE:HLN - Free Report) by 42.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 613,099 shares of the company's stock after selling 448,300 shares during the quarter. Renaissance Technologies LLC's holdings in Haleon were worth $5,849,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of HLN. Sierra Ocean LLC purchased a new position in shares of Haleon during the fourth quarter valued at about $26,000. Versant Capital Management Inc grew its holdings in Haleon by 2,029.1% during the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company's stock valued at $34,000 after buying an additional 3,348 shares in the last quarter. Geneos Wealth Management Inc. bought a new stake in Haleon in the 4th quarter worth approximately $35,000. Spire Wealth Management purchased a new stake in shares of Haleon during the 4th quarter worth approximately $39,000. Finally, FIL Ltd boosted its position in shares of Haleon by 45.7% during the 4th quarter. FIL Ltd now owns 4,049 shares of the company's stock valued at $39,000 after acquiring an additional 1,270 shares during the last quarter. 6.67% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
HLN has been the topic of several research reports. Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Haleon in a research report on Monday, March 3rd. Sanford C. Bernstein cut shares of Haleon from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 8th. Hsbc Global Res lowered Haleon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. HSBC restated a "hold" rating on shares of Haleon in a research report on Wednesday, March 5th. Finally, Morgan Stanley downgraded Haleon from an "overweight" rating to an "equal weight" rating in a research report on Friday, January 10th. Six analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $10.95.
Get Our Latest Stock Analysis on HLN
Haleon Trading Down 0.3 %
Shares of HLN traded down $0.03 during mid-day trading on Monday, reaching $10.19. 9,046,200 shares of the company's stock traded hands, compared to its average volume of 7,155,621. Haleon plc has a 12 month low of $8.12 and a 12 month high of $10.80. The stock has a market cap of $46.02 billion, a P/E ratio of 29.97, a P/E/G ratio of 2.82 and a beta of 0.24. The stock's 50-day moving average is $10.10 and its two-hundred day moving average is $9.80. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58.
Haleon (NYSE:HLN - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $0.05 EPS for the quarter. The business had revenue of $3.54 billion for the quarter, compared to the consensus estimate of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. Research analysts forecast that Haleon plc will post 0.43 earnings per share for the current fiscal year.
Haleon Increases Dividend
The company also recently declared a -- dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be given a dividend of $0.1166 per share. This represents a dividend yield of 1.6%. This is a positive change from Haleon's previous -- dividend of $0.05. The ex-dividend date is Friday, April 25th. Haleon's dividend payout ratio is presently 58.97%.
Haleon Company Profile
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
See Also
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
